From Science to Clinical Practice: Advancing Heart Failure Care with ReDS™ Pro

About

Sensible Medical Innovations is a pioneering healthcare technology company dedicated to transforming chronic disease management through innovative, non-invasive monitoring solutions.

Founded with a commitment to improve patient outcomes and reduce the burden of hospital readmissions, Sensible Medical has developed the groundbreaking ReDS (Remote Dielectric Sensing) system. This advanced technology allows for precise, real-time monitoring of lung fluid levels, providing clinicians with actionable insights to improve the life of patients with heart failure and other fluid-related conditions.

VISION

To revolutionize heart failure management and improve patient quality of life worldwide through advanced, non-invasive monitoring solutions.

At Sensible Medical, we envision a future where innovative medical technology empowers healthcare providers to manage fluid-related conditions more effectively, enhancing patient outcomes, lowering healthcare costs and enabling proactive patient-centered care.

MISSION

Our mission is to set the standard in fluid management by empowering healthcare providers with innovative, non-invasive solutions that enhance patient outcomes, reduce hospitalizations, and transform the management of heart failure and fluid-related conditions. Through our pioneering ReDS technology, we aim to provide clinicians with accurate, real-time insights into lung fluid levels, enabling proactive, personalized care for patients.

Management

Avi Ludomirski

CEO

Aital Bergman

CFO

Nahum Hai

COO

John DeChellis

EVP Sales

Shlomi Bergida

VP Product

Nadav Mizrahi

VP R&D

Ronit Shaanan

VP Quality Affairs

Elad Gelbart

VP Clinical Affairs

Advisory

William Abraham

Ohio State University

Stefan Anker

Charité University

Dan Bensimhon

Cone Health

Junbo Ge

Zhongshan Hospital, Fudan University

Skip to content